Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
Clinical trial NCT04515524 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04515524
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-05
- Primary completion
- 2026-11-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.